Daiwa Securities Group’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $288K | Buy |
7,835
+3,689
| +89% | +$136K | ﹤0.01% | 920 |
|
2025
Q1 | $147K | Buy |
4,146
+359
| +9% | +$12.7K | ﹤0.01% | 953 |
|
2024
Q4 | $165K | Buy |
3,787
+3,178
| +522% | +$138K | ﹤0.01% | 954 |
|
2024
Q3 | $28K | Hold |
609
| – | – | ﹤0.01% | 1090 |
|
2024
Q2 | $24K | Hold |
609
| – | – | ﹤0.01% | 1124 |
|
2024
Q1 | $20K | Sell |
609
-61
| -9% | -$2K | ﹤0.01% | 1131 |
|
2023
Q4 | $19K | Buy |
670
+313
| +88% | +$8.88K | ﹤0.01% | 1124 |
|
2023
Q3 | $10K | Hold |
357
| – | – | ﹤0.01% | 1123 |
|
2023
Q2 | $10K | Hold |
357
| – | – | ﹤0.01% | 1131 |
|
2023
Q1 | $8K | Hold |
357
| – | – | ﹤0.01% | 1117 |
|
2022
Q4 | $9K | Buy |
357
+80
| +29% | +$2.02K | ﹤0.01% | 1113 |
|
2022
Q3 | $5K | Hold |
277
| – | – | ﹤0.01% | 1156 |
|
2022
Q2 | $5K | Buy |
277
+62
| +29% | +$1.12K | ﹤0.01% | 1163 |
|
2022
Q1 | $5K | Hold |
215
| – | – | ﹤0.01% | 1171 |
|
2021
Q4 | $5K | Sell |
215
-37
| -15% | -$860 | ﹤0.01% | 1195 |
|
2021
Q3 | $7K | Buy |
252
+109
| +76% | +$3.03K | ﹤0.01% | 1155 |
|
2021
Q2 | $5K | Hold |
143
| – | – | ﹤0.01% | 1073 |
|
2021
Q1 | $7K | Buy |
143
+18
| +14% | +$881 | ﹤0.01% | 1060 |
|
2020
Q4 | $5K | Buy |
+125
| New | +$5K | ﹤0.01% | 1055 |
|